'Take 5': Form Follows Function

This week's ‘Take 5’ selection captures a musculoskeletal and tissue-engineering field in rapid transition, moving from proof-of-concept constructs toward developmentally informed, functionally integrated platforms that are beginning to close the gap between the bench and the clinic.

A central theme across this week’s articles is the growing recognition that biological fidelity requires more than cell-type selection; it requires architecture.  The scaffold-free osteochondral assembloid described by Peng et al. exemplifies this principle.   By spatially bioassembling iPSC-derived chondrocyte and periosteum-derived organoids into a bilayered construct, the authors recapitulate the distinct chondral and osteo zones of native tissue, including a self-organising transitional interface, without exogenous scaffold or hydrogel.  Orthotopic implantation into full-thickness rat knee defects produced outcomes comparable to native tissue, establishing a developmentally inspired design framework with clear translational relevance for osteochondral repair.

Disease insight this week is increasingly spatially and transcriptomically resolved.  Choi et al. combine osteoblast-specific lineage tracing with spatially resolved laser-activated cell sorting to identify TGF-β signalling as a key driver of osteoblast quiescence and transition to bone-lining cells.  Functional validation in bone organoids on demineralised bone paper and confirmed benefits from dual TGF-β and sclerostin inhibition in vivo, illustrate how organoid systems are being embedded within mechanistic discovery pipelines rather than positioned merely as downstream validation tools.  Crucially, the authors explicitly frame future humanised bone organoid integration as the next translational step, reflecting the field’s growing regulatory momentum under the FDA Modernization Act 2.0.

Technologically, the field is grappling with the perennial challenge of simultaneous demands: printability, mechanical strength, biocompatibility, and zonal biomimicry in a single construct.  The comprehensive review of 3D bioprinting for cartilage organoids by Han et al.  is candid about current limitations.  Constructs remain largely foetal-like in phenotype, clinically relevant vascularisation is unsolved, and cross-laboratory standardisation and GMP-compliant manufacturing pipelines are absent.  Yet the authors identify 4D bioprinting, organoid-on-a-chip integration, and AI-driven parameter optimisation as the most promising convergent directions, signalling that the route to translation runs through platform convergence rather than incremental material improvement alone.

Alongside hard-tissue modelling, softer biological systems are advancing with equal sophistication.  The review by Ianoși et al. on transcriptional regulation in skin repair maps how wound healing trajectories are governed by dynamic RNA regulatory networks across keratinocyte, fibroblast, vascular, and immune compartments, and proposes RNA-guided modulation of hiPSC-derived skin organoids as a preclinical strategy for steering regenerative outcomes.  While the authors are appropriately measured in noting that full integration of these components remains hypothetical, the framework itself reflects a broader maturation in the field: organoid design is increasingly being informed by the multi-layered molecular logic of the tissues they seek to replicate.

The 3Rs review by Cagle et al. offers a field-level perspective on where in vitro bone models genuinely stand.  Self-assembling trabecular organoids, microfluidic bone-on-a-chip devices, and AI-assisted digital twin frameworks are best positioned today as fail-early screening tools that reduce exploratory animal use rather than outright replacements, given persistent challenges in vascularisation, Haversian microarchitecture, and immune integration.  Yet the review also identifies practical reduction gains immediately available through longitudinal imaging and rigorous experimental design, reinforcing that responsible model development and meaningful 3Rs progress can advance in parallel rather than in sequence.

Overall, the trajectory across this week’s selection is one of increasing developmental precision and convergent platform design.  Whether through assembloid-based osteochondral repair, spatially resolved target discovery in bone, AI-guided bioprinting, or RNA-programmed skin organoids, the field is steadily building toward musculoskeletal and tissue-engineering platforms that are architecturally faithful, mechanistically grounded, and translationally purposeful.

Source Articles:

Han, Z. et al. (2026) Advances and Challenges in 3D Bioprinting of Cartilage Organoids: From Material Innovation to Functional Regeneration. International Journal of Nanomedicine 21; https://www.worc.community/documents/advances-and-challenges-in-3d-bioprinting-of-cartilage-organoids-from-material-innovation-to-functional-regeneration

Cagle, A.L. et al. (2026) Advancing the 3Rs in bone tissue engineering: emerging in vitro, in silico, and refined in vivo strategies. Frontiers in Physiology; https://www.worc.community/documents/advancing-the-3rs-in-bone-tissue-engineering-emerging-in-vitro-in-silico-and-refined-in-vivo-strategies

Choi, A. et al. (2026) Spatially resolved osteoblast-traced transcriptomics uncovers TGF-β as a combination target with sclerostin in osteoporosis. Bone Research; https://www.worc.community/documents/spatially-resolved-osteoblast-traced-transcriptomics-uncovers-tgf-as-a-combination-target-with-sclerostin-in-osteoporosis

Ianoși, E.S. et al. (2026) RNA Coding and Transcriptional Regulation in Skin Repair: Insights from Single-Cell Profiling and Implications for Organoid-Based Regenerative Strategies. Life 16; https://www.worc.community/documents/rna-coding-and-transcriptional-regulation-in-skin-repair-insights-from-single-cell-profiling-and-implications-for-organoid-based-regenerative-strategies

Peng, L. et al. (2026) Synchronizing the Osteochondral Regeneration Process through Spatial Patterning of Stable and Hypertrophic Cartilage Organoids. Advanced Materials; https://www.worc.community/documents/synchronizing-the-osteochondral-regeneration-process-through-spatial-patterning-of-stable-and-hypertrophic-cartilage-organoids

'Tech Highlight': Engineering Crosstalk – A Modular Organ-on-Chip Platform for Physiologically Relevant Co-Culture

A persistent challenge in organ-on-chip design is recreating not just individual tissues, but the dynamic dialogue between them.  A new study published in Micromachines (DOI: 10.3390/mi17050609) addresses this directly, presenting a modular, compartmentalised microfluidic platform that uses tuneable porous barriers to support multi-tissue co-culture with precisely engineered inter-compartmental crosstalk, all fabricated without the requirement for cleanroom processing.

Central to the platform is a family of porous barrier (PB) architectures, fabricated using digital light processing (DLP) 3D printing, that physically separate cell populations while sustaining controlled fluid and molecular exchange between compartments.  Unlike conventional organ-on-chip configurations that rely on fixed porous membranes or tubing-based interconnections, these barriers can be oriented in multiple geometries, perpendicular, parallel, curved, or meandering, and pores can be positioned at any height within the wall.  This design flexibility translates directly into biological versatility: four distinct organisational layouts are demonstrated, each suited to a different class of tissue interaction.

The linear arrangement, in which compartments are aligned in series along the flow direction, is well suited to modelling sequential organ axes such as gut–liver, where directional metabolite transport is the key variable.  The interdigitated design maximises shared interfacial area between two populations, supporting dense bidirectional paracrine exchange,  ideal for closely coupled cell types.  The honeycomb architecture positions a central compartment surrounded by six interconnected peripheral chambers, enabling radially symmetric crosstalk among three or more cell types simultaneously, mirroring the structure of the hepatic lobule or secondary lymphoid tissue.  Finally, a tri-compartment perfusion device allows parallel chambers to receive synchronised or independent stimulation via common inlet and outlet channels.

As a proof of concept, the team deployed the interdigitated design to co-culture differentiated human adipocytes and monocyte-derived macrophages, modelling the immune infiltration that characterises inflamed adipose tissue in obesity.  Over a 21-day culture period, the system reproduced the hallmark immune-metabolic signature.  Progressive reduction in insulin-stimulated glucose uptake coupled with elevated secretion of the pro-inflammatory cytokines TNF-α and IL-6, most pronounced when macrophages were present.  Crucially, these responses were difficult to capture in conventional static co-culture, where concentration gradients collapse and the media-to-cell volume ratio diverges sharply from physiological conditions.  The reduced volume and continuous perfusion of the microfluidic system restored a more in vivo-like exposure environment, amplifying the sensitivity of the readout.

From a fabrication standpoint, the platform’s reliance on a single DLP 3D-printing workflow is a practical advance.  All compartment topologies, from two-chamber layouts to honeycomb and multi-compartment perfusion geometries, are accessible without photolithography or multi-layer bonding, lowering the barrier to iterative design and broadening access to laboratories without specialist infrastructure.  The planar co-culture geometry also places all compartments in a single optical plane, simplifying compatibility with standard inverted microscopes and high-content imaging systems.

The authors acknowledge that biological validation remains focused on a single disease model, and that integration of embedded sensors, quantitative mass-transfer modelling, and primary human immune cells will be necessary to fully exploit the platform’s capabilities.  Nonetheless, the study establishes a clear and generalisable framework: by treating barrier geometry as a biologically motivated design variable, rather than an engineering constraint, the platform offers a principled route to constructing microphysiological systems whose architecture is matched to the specific crosstalk it is intended to capture.

In a field where the gap between engineering elegance and biological fidelity remains wide, this work offers a practical path toward closing it.

Source Article:

Qasem Ramadan, Rana Hazaymeh & Mohamed Zourob  (2026) Rapid Prototyping of Compartmentalized 3D Microfluidic Devices for Organotypic Cell Culture. Micromachines; https://www.worc.community/documents/rapid-prototyping-of-compartmentalized-3d-microfluidic-devices-for-organotypic-cell-culture

Hope you enjoyed this week's WORC Break!    As always, it would be great to hear your feedback on this feature, share it and join the discussion!  Bookmark this page to stay on top of all things 3D and look forward to connecting with you!

Editor